Weight-loss drugs linked to rare vision loss: Harvard study

No Title

Novo Nordisk (NVO) and Eli Lilly (LLY) shares dip in reaction to a Harvard study that found GLP-1 weight-loss drugs Ozempic and Wegovy could be linked to rare cases of vision loss. Yahoo Finance health reporter Anjalee Khemlani explains the study's findings.

Report

MAGA President

Written by OldTimerNW

RANK: MAGA President

UPVote if you like this

Leave a Reply

Your email address will not be published. Required fields are marked *